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April 20111162 AbstractsConclusions: The best medical therapy for carotid disease is not
optimal in the part of the German health-care system observed in this
study. We strongly advocate similar audits in other health-care areas and
systems.
A Systematic Review of Percutaneous Mechanical Thrombectomy in
the Treatment of Deep Venous Thrombosis
Karthikesalingam A., Young E.L., Hinchliffe R.J., Loftus I.M., Thompson
M.M., Holt P.J.E. Eur J Vasc Endovasc Surg 2011;41:554-65.
Background: In selected cases of deep vein thrombosis (DVT), catheter-
directed thrombolysis (CDT) may be superior to conventional treatment with
anticoagulation alone, as it can preventDVT recurrence and the development of
post-thrombotic syndrome (PTS). Percutaneous mechanical thrombectomy
(PMT) devices offer a minimally invasive adjunctive strategy and the data on
these emerging technologies require review.Readers can access EJVES articles at http://intl.eMethods: Medline, trial registries, conference proceedings and article
eference lists were searched to identify case series reporting PMTdevice use.
ata were extracted for review.
Results: 16 retrospective case series have reported the use of rheolytic,
otational, or ultrasound-assisted PMT in a total of 481 patients. No
andomised trials were available. Technical success of 82–100% was reported
ith Grade II or III lysis in 83–100% of patients. The different devices all
ppeared to be safe, with no reported procedure-related deaths or strokes
nd 1% incidence of symptomatic PE. Bleeding complications were re-
orted in 6/16 studies, in which 4–14% of patients required transfusion
global incidence 11/146 patients, 7.5%).
Conclusion: PMT appears feasible and safe, though the level of evi-
ence available is poor. Major RCTs and registry data are required to
etermine the economic and clinical benefit of various devices used alone or
n combination, for differing thrombus characteristics and clinical scenarios.
ntil these data are available there is little substantial evidence to support theObjectives: To review the evidence for PMT devices in DVT in terms
of case selection, technical feasibility and procedural outcomes.
routine use of PMT over CDT alone.lsevierhealth.com/journals/ejvs/default.cfm
